Drug Discovery and Development
- All
- Analytical Services
- Bioanalytical Services
- Bioassay Development
- Biologics, Proteins, Vaccines
- Biosimilars
- Chemistry
- Clinical Trials
- Drug Delivery
- Drug Development
- Drug Discovery
- Formulation Development
- Information Technology
- Laboratory Testing
- Methods Development
- Microbiology
- Preclinical Outsourcing
- R&D
- Toxicology
-
Clinical Trials
Impact of COVID-19 on Winning New Business
Wuxi Clinical’s Vice President of Biometrics, David Ng, talks about the impact of COVID-19 on clinical trials and business relationsOnline Exclusives Tim Wright, Editor, Contract Pharma 06.03.20
-
Clinical Trials | Drug Development | Trials & Filings
Octapharma Extends Funding for COVID-19 Study
Study evaluating using IVIG as investigational coronavirus treatment for adults experiencing respiratory failure.Contract Pharma Staff 06.03.20
-
Clinical Trials | Drug Development | Industry News | Trials & Filings
FSD Pharma Gets Go Ahead for Phase IIa COVID-19 Trial
To evaluate FSD-201 to treat COVID-19; anti-inflammatory properties aim to avoid the cytokine storm.Contract Pharma Staff 06.03.20
-
Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Industry News
Novavax Selects AGC Biologics to Manufacture Novel COVID-19 Vax
To provide large-scale GMP production of Matrix-M, the adjuvant component of Novavax’ coronavirus vaccine candidate, NVX-CoV2373.Contract Pharma Staff 06.03.20
-
Breaking News | Clinical Trials | Industry News | Information Technology
Almac Introduces Simplify
An advanced IRT solution enabling faster clinical trial start-upContract Pharma Staff 06.02.20
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Industry News | R&D
Pfizer Unveils $500M Biotech Fund
New program to support continued biotechnology innovation across a portfolio of clinical-stage biotechnology companiesContract Pharma Staff 06.02.20
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Industry News
Emergent Joins U.S. Govt.’s COVID-19 Vax Acceleration Efforts in Landmark Deal
Public-private partnership for COVID-19 vaccine development and manufacturing valued at approximately $628 millionContract Pharma Staff 06.02.20
-
Breaking News | Industry News | Information Technology | Promotions & Moves
Catalent Names Charles Lickfold as Chief Information Officer
Succeeds John McGill who will retire in the fallContract Pharma Staff 06.02.20
-
Analytical Services | Breaking News | CRO News | Drug Development | Industry News | Preclinical Outsourcing
Frontage Establishes Center of Excellence
Quantitative whole-body autoradiography CoE will be located in Exton, PA and headed by Michael Potchobia.Contract Pharma Staff 06.02.20
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Industry News
MilliporeSigma and Baylor Enter COVID-19 Vax Pact
Will focus on process development and improvements for manufacturing Baylor's Covid-19 vaccine candidatesContract Pharma Staff 06.02.20
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Facilities | Industry News
POINT Biopharma to Launch First US Manufacturing Facility
Next-gen oncology company plans long-term manufacturing growth, 100+ high-wage jobs in IndianapolisContract Pharma Staff 06.02.20
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Industry News
Lilly, AbCellera Dose First Patients with COVID-19 Antibody
Phase 1 study of LY-CoV555 is the world's first study of a potential antibody treatment designed to fight COVID-19Contract Pharma Staff 06.01.20
-
Breaking News | Clinical Trials | Industry News
LabCorp Launches New COVID-19 Clinical Trial Site
To connect patients with US research trials; streamlining recruitment into studies to speed researchContract Pharma Staff 06.01.20
-
Clinical Trials | Trials & Filings
Proteostasis Gets Positive Preclinical Results in COVID-19
PTI-129, a once-daily, oral small molecule demonstrates the potential to reduce viral protein production in host cells.Contract Pharma Staff 06.01.20
-
Breaking News | Collaborations & Alliances | Drug Development
Junshi Biosciences, Merck Partner on SCCHN Combo Therapy
To study anti-PD-1 mAb toripalimab (TUOYI) in combination with Cetuximab (Erbitux) in metastatic squamous cell carcinomas of the head and neck in China.Contract Pharma Staff 06.01.20
-
Breaking News | Collaborations & Alliances | Drug Development
Regeneron, Intellia Expand CRISPR/Cas9 Alliance
Provides Regeneron with rights to develop additional CRISPR/Cas9-based therapeutic targets and to jointly develop potential products for hemophilia A and B.Contract Pharma Staff 06.01.20
-
Breaking News | Drug Development | Industry News
Lilly's CYRAMZA Gains Sixth FDA Approval
CYRAMZA plus erlotinib is the first FDA-approved anti-VEGFR/EGFR TKI combination therapy for metastatic EGFR-mutated NSCLC.Contract Pharma Staff 06.01.20
-
Breaking News | Collaborations & Alliances | Drug Development
AbbVie, Jacobio Pharma Enter Strategic Pact
To develop and commercialize SHP2 inhibitors targeting a key node in cancer and immune cells.Contract Pharma Staff 06.01.20
-
Drug Development | Industry News | QA/QC
USP Provides Guidelines for rFC Reagent
Recombinant Factor C critical to development of vaccines and other sterile pharmaceutical products.Contract Pharma Staff 06.01.20
-
Breaking News | Clinical Trials | Drug Development | Industry News
Daiichi Sankyo, Syneos Health Form Strategic ADC Alliance
Syneos to provide strategic and operational services for three lead Daiichi antibody drug conjugates.Contract Pharma Staff 06.01.20
